共 90 条
[81]
Raymond E., Faivre S., Armand J.P., Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy, Drugs, 60, SUPPL. 1, pp. 15-23, (2000)
[82]
Kim J.W., Kim Y.T., Kim D.S., Et al., Expression of epidermal growth factor receptor in carcinoma of the cervix, Gynecol. Oncol., 60, pp. 283-287, (1996)
[83]
Akerman G.S., Tolleson W.H., Brown K.L., Et al., Human papillomavirus typ 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life spaqn of normal human keratinocytes, Cancer Res., 61, pp. 3837-3843, (2001)
[84]
Fan Z., Shang B.Y., Lu Y., Et al., Reciprocal changes in p27 (Kip 1) and p21 (Cip 1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors, Clin. Cancer Res., 3, pp. 1943-1948, (1997)
[85]
Shepherd F.A., Pereira J., Ciuleanu T.E., Et al., A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy, J. Clin. Oncol., 22, (2004)
[86]
Ng M., Cunningham D., Cetuximab (Erbitux): An emerging targeted therapy for epidermal growth factor receptor-expressing tumours, Int. J. Clin. Pract., 58, pp. 970-976, (2004)
[87]
Tewari K.S., DiSaia P.J., Primary prevention of uterine cervix cancer: Focus on vaccine history and current strategy, Obstet. Gynecol. Clin. North Am., 29, pp. 843-868, (2002)
[88]
Im S.S., Monk B.J., New developments in the treatment of invasive cervical cancer, Obstet. Gynecol. Clin. North Am., 29, pp. 659-672, (2002)
[89]
Lim H.Y., Ahn M., Chung H.C., Et al., Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus, Cancer Gene Ther., 11, pp. 532-538, (2004)
[90]
Boabang P., Kurbacher C.M., Kohlhagen H., Et al., Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor chemosensitivity assay, Anticancer Drugs, 11, pp. 843-848, (2000)